S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.3 DKK
Market Cap: 26m DKK
Have any thoughts about
Stenocare A/S?
Write Note

Stenocare A/S
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stenocare A/S
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Accounts Payable
kr1.3m
CAGR 3-Years
-21%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Accounts Payable
kr24.1B
CAGR 3-Years
39%
CAGR 5-Years
33%
CAGR 10-Years
23%
H Lundbeck A/S
CSE:HLUN A
Accounts Payable
kr4.4B
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Accounts Payable
kr128m
CAGR 3-Years
20%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
23.6m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.45 DKK
Overvaluation 66%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Accounts Payable?
Accounts Payable
1.3m DKK

Based on the financial report for Dec 31, 2023, Stenocare A/S's Accounts Payable amounts to 1.3m DKK.

What is Stenocare A/S's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
16%

Over the last year, the Accounts Payable growth was -58%. The average annual Accounts Payable growth rates for Stenocare A/S have been -21% over the past three years , 16% over the past five years .

Back to Top